nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India
|
Kalra, Sanjay |
|
|
14 |
1 |
p. 29-45 |
artikel |
2 |
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
|
Lingvay, Ildiko |
|
|
14 |
1 |
p. 123-137 |
artikel |
3 |
COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?
|
Heald, Adrian H. |
|
|
14 |
1 |
p. 193-204 |
artikel |
4 |
Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes
|
Oliver, Nick |
|
|
14 |
1 |
p. 1-10 |
artikel |
5 |
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study
|
Candido, Riccardo |
|
|
14 |
1 |
p. 77-92 |
artikel |
6 |
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China
|
Liu, Lei |
|
|
14 |
1 |
p. 93-107 |
artikel |
7 |
Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
|
Abu-Alfa, Ali K. |
|
|
14 |
1 |
p. 11-28 |
artikel |
8 |
Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy
|
Wang, Shun-hua |
|
|
14 |
1 |
p. 167-178 |
artikel |
9 |
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study
|
Huang, Rongdong |
|
|
14 |
1 |
p. 139-151 |
artikel |
10 |
Single-Field Fundus Photography for Screening of Diabetic Retinopathy: The Prevalence and Associated Factors in a Population-Based Study
|
Soleimani, Mohammadreza |
|
|
14 |
1 |
p. 205-217 |
artikel |
11 |
Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys
|
Krishnamoorthy, Yuvaraj |
|
|
14 |
1 |
p. 63-75 |
artikel |
12 |
Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic
|
Swaich, Harshpreet |
|
|
14 |
1 |
p. 153-165 |
artikel |
13 |
Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study
|
Kim, Sang-Yong |
|
|
14 |
1 |
p. 109-121 |
artikel |
14 |
Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis
|
Wang, Hong |
|
|
14 |
1 |
p. 47-61 |
artikel |
15 |
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
|
Matsuhisa, Munehide |
|
|
14 |
1 |
p. 219-236 |
artikel |
16 |
Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
|
Gentile, Sandro |
|
|
14 |
1 |
p. 179-191 |
artikel |